SC
NVO

Syon Capital’s Novo Nordisk NVO Stock Holding History

Syon Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Buy
11,348
+1,064
+10% +$50.4K 0.02% 625
2025
Q4 		$523K Sell
10,284
-1,151
-10% -$58.9K 0.03% 548
2025
Q3 		$635K Sell
11,435
-10,069
-47% -$589K 0.03% 405
2025
Q2 		$1.48M Sell
21,504
-2,257
-9% -$154K 0.1% 146
2025
Q1 		$1.65M Sell
23,761
-1,518
-6% -$125K 0.13% 111
2024
Q4 		$2.17M Sell
25,279
-1,590
-6% -$172K 0.2% 83
2024
Q3 		$3.2M Sell
26,869
-1,136
-4% -$152K 0.28% 63
2024
Q2 		$4M Buy
28,005
+243
+0.9% +$32.2K 0.37% 50
2024
Q1 		$3.56M Sell
27,762
-27,856
-50% -$3.32M 0.34% 53
2023
Q4 		$5.75M Buy
55,618
+32,421
+140% +$3.21M 0.24% 64
2023
Q3 		$2.11M Buy
+23,197
New +$2.04M 0.26% 59

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Syon Capital's NVO Position: Q1 2026 in Review

Syon Capital increased its Novo Nordisk (NVO) stake by 10% in Q1 2026, buying an estimated $50.4K and bringing the position to 11,348 shares worth $417K. The position accounts for 0.02% of the portfolio, ranked #625.

Syon Capital first reported a position in NVO in Q3 2023 and has held it in 11 quarters since. The position peaked at $5.75M in Q4 2023. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Syon Capital held 11,348 shares of Novo Nordisk worth $417K as of Q1 2026.
  • Syon Capital bought 1,064 Novo Nordisk shares in Q1 2026, an estimated $50.4K.
  • Novo Nordisk made up 0.02% of Syon Capital's portfolio in Q1 2026, its #625 holding.
  • Syon Capital first reported a position in Novo Nordisk in Q3 2023 and has held it in 11 quarters since.
  • Syon Capital's Novo Nordisk position peaked at $5.75M in Q4 2023.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.